Oxygen Biotherapeutics Inc (OXBT)

3.71
0.06 1.71
NASDAQ : Health Care
Prev Close 3.65
Open 3.63
Day Low/High 3.60 / 3.83
52 Wk Low/High 2.88 / 5.00
Volume 54.05K
Avg Volume 158.40K
Exchange NASDAQ
Shares Outstanding 28.11M
Market Cap 113.55M
EPS -6.29
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Oxygen Biotherapeutics To Present At Wedbush 2014 Life Sciences Management Access Conference

Oxygen Biotherapeutics To Present At Wedbush 2014 Life Sciences Management Access Conference

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, Chief...

Oxygen Biotherapeutics Announces Collaboration With Imperial College London To Accelerate Enrollment Of LeoPARDS Trial

Oxygen Biotherapeutics Announces Collaboration With Imperial College London To Accelerate Enrollment Of LeoPARDS Trial

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced a collaboration with...

Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial Results

Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial Results

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for the...

Oxygen Biotherapeutics To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On July 29, 2014

Oxygen Biotherapeutics To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On July 29, 2014

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that the Company will host...

Recent Scientific Publications Highlight Potential Benefits Of Levosimendan In Cardiac Surgery And Additional Critical Care Conditions

Recent Scientific Publications Highlight Potential Benefits Of Levosimendan In Cardiac Surgery And Additional Critical Care Conditions

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today highlighted three recent review...

Oxygen Biotherapeutics Announces Formation Of Steering Committee For Phase 3 LEVO-CTS Trial Of Levosimendan

Oxygen Biotherapeutics Announces Formation Of Steering Committee For Phase 3 LEVO-CTS Trial Of Levosimendan

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced the formation of a steering...

Oxygen Biotherapeutics Inc., Announces The Appointment Of Industry Veteran Gerald Proehl To Its Board Of Directors

Oxygen Biotherapeutics Inc., Announces The Appointment Of Industry Veteran Gerald Proehl To Its Board Of Directors

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has appointed...

Oxygen Biotherapeutics Inc. Provides An Update On Communication With The FDA Regarding Oxycyte Development Program

Oxygen Biotherapeutics Inc. Provides An Update On Communication With The FDA Regarding Oxycyte Development Program

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has received...

Oxygen Biotherapeutics Prices $52 Million Underwritten Offering

Oxygen Biotherapeutics Prices $52 Million Underwritten Offering

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has priced an...

Oxygen Biotherapeutics Announces Proposed Public Offering

Oxygen Biotherapeutics Announces Proposed Public Offering

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today its intention, subject to...

Oxygen Biotherapeutics Inc. Provides An Update On Communication With The FDA Regarding Oxycyte Development Program

Oxygen Biotherapeutics Inc. Provides An Update On Communication With The FDA Regarding Oxycyte Development Program

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has been notified...

5 Stocks Ready to Explode Higher

5 Stocks Ready to Explode Higher

Here's a look at five stocks with potentially explosive chart patterns.

Newly Published Cardiac Surgery Study Provides Further Evidence That Levosimendan Significantly Improves Post-operative Kidney Function.

Newly Published Cardiac Surgery Study Provides Further Evidence That Levosimendan Significantly Improves Post-operative Kidney Function.

Oxygen Biotherapeutics, Inc., (“OBI”) (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that a...

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

Today's Dead Cat Bounce Stock Is Oxygen Biotherapeutics (OXBT)

Today's Dead Cat Bounce Stock Is Oxygen Biotherapeutics (OXBT)

Trade-Ideas LLC identified Oxygen Biotherapeutics (OXBT) as a "dead cat bounce" (down big yesterday but up big today) candidate

5 Under-$10 Biotech Stocks to Watch

5 Under-$10 Biotech Stocks to Watch

Keep these biotech stocks on your radar.

Oxygen Biotherapeutics To Present At Two Upcoming Healthcare Investor Conferences

Oxygen Biotherapeutics To Present At Two Upcoming Healthcare Investor Conferences

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that it is...

Oxygen Biotherapeutics Announces Key Details Of Phase 3 Trial Protocol For Levosimendan

Oxygen Biotherapeutics Announces Key Details Of Phase 3 Trial Protocol For Levosimendan

Oxygen Biotherapeutics, Inc. (“OBI”) (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that ...

Oxygen Biotherapeutics Provides A Business Review And Update In Conjunction With Filing Of Second Quarter Fiscal Year 2014 Financials

Oxygen Biotherapeutics Provides A Business Review And Update In Conjunction With Filing Of Second Quarter Fiscal Year 2014 Financials

Oxygen Biotherapeutics, Inc.,(“OBI”) (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that it...

Oxygen Biotherapeutics Selects Duke Clinical Research Institute To Conduct Phase 3 Trial Of Levosimendan

Oxygen Biotherapeutics Selects Duke Clinical Research Institute To Conduct Phase 3 Trial Of Levosimendan

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT), a pharmaceutical company focused on developing drugs for the acute care market, today announced that it has selected Duke University’s Duke Clinical Research...

Oxygen Biotherapeutics To Host 2013 Annual Meeting Of Shareholders

Oxygen Biotherapeutics To Host 2013 Annual Meeting Of Shareholders

Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a developer of oxygen-carrying therapeutics, today announced it will webcast its 2013 Annual Meeting of Shareholders on Wednesday, December 4, 2013 beginning at 9:00am ET...

Oxygen Biotherapeutics (OXBT) Showing Signs Of A Dead Cat Bounce Today

Oxygen Biotherapeutics (OXBT) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified Oxygen Biotherapeutics (OXBT) as a "dead cat bounce" (down big yesterday but up big today) candidate

Biotech Stocks Partying Like It's 1999

Biotech Stocks Partying Like It's 1999

After a weak October, biotech stocks have rebounded in a big way in November. The sector is on pace for an history year of absolute and relative performance.

Stock To Watch: Oxygen Biotherapeutics (OXBT) In Perilous Reversal

Stock To Watch: Oxygen Biotherapeutics (OXBT) In Perilous Reversal

Trade-Ideas LLC identified Oxygen Biotherapeutics (OXBT) as a "perilous reversal" (up big yesterday but down big today) candidate